Loading clinical trials...
Loading clinical trials...
A Phase II, Multi-centre Study, of Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases From Non-small Cell Lung Cancer and Renal Cell Cancer
Conditions
Interventions
Nivolumab
Radiosurgery
Locations
4
Canada
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Start Date
June 2, 2017
Primary Completion Date
January 31, 2021
Completion Date
December 31, 2023
Last Updated
June 28, 2024
NCT07130786
NCT05789589
NCT07227415
NCT05419076
NCT06280300
NCT04711824
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions